Search hospitals > Illinois > Harvey
Ingalls Memorial Hospital
Claim this profileHarvey, Illinois 60426
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Pancreatic Cancer
Conducts research for Breast cancer
267 reported clinical trials
5 medical researchers
Summary
Ingalls Memorial Hospital is a medical facility located in Harvey, Illinois. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Pancreatic Cancer, Breast cancer and other specialties. Ingalls Memorial Hospital is involved with conducting 267 clinical trials across 370 conditions. There are 5 research doctors associated with this hospital, such as Mark F. Kozloff, Ivy Abraham, James A. Wallace, and Danielle Sterrenberg, MD.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Mark F. KozloffIngalls Memorial Hospital6 years of reported clinical research
Studies Breast cancer
Studies Colorectal Cancer
26 reported clinical trials
77 drugs studied
Ivy AbrahamIngalls Memorial Hospital2 years of reported clinical research
Expert in Breast Cancer
Studies Breast cancer
16 reported clinical trials
35 drugs studied
James A. WallaceIngalls Memorial Hospital2 years of reported clinical research
Studies Lung Cancer
Studies Cancer
19 reported clinical trials
64 drugs studied
Danielle Sterrenberg, MDIngalls Memorial Hospital7 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
9 reported clinical trials
18 drugs studied
Clinical Trials running at Ingalls Memorial Hospital
Lung Cancer
Breast Cancer
Bladder Cancer
Cancer
Prostate Cancer
Breast cancer
Esophageal cancer
Ovarian Cancer
Pancreatic Cancer
Uterine Cancer
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Blood Sample Collection
for Cancer Detection
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.
Recruiting1 award N/A9 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Ingalls Memorial Hospital?
Ingalls Memorial Hospital is a medical facility located in Harvey, Illinois. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Pancreatic Cancer, Breast cancer and other specialties. Ingalls Memorial Hospital is involved with conducting 267 clinical trials across 370 conditions. There are 5 research doctors associated with this hospital, such as Mark F. Kozloff, Ivy Abraham, James A. Wallace, and Danielle Sterrenberg, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.